Resveratrol and the pharmacology of aging: A new vertebrate model to validate an old molecule

Cell Cycle

Volumn 5, Issue 10, 2006, Pages 1027-1032

  Valenzano, Dario Riccardo ^a,b   Cellerino, Alessandro ^a,b  

^a SCUOLA NORMALE SUPERIORE   (Italy)

^b CNR   (Italy)

Author keywords

Aging; Animal model; Longevity; Nothobranchius; Resveratrol

Indexed keywords

2 PYRROLIDONE DERIVATIVE; 3,3 DIETHYL 2 PYRROLIDINE; 4 PHENYLBUTYRIC ACID; ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTICONVULSIVE AGENT; ANTIOXIDANT; BUTYLCRESOL; ETHOSUXIMIDE; GINKGO BILOBA EXTRACT; GLUCURONIDE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; PHYTOALEXIN; RESVERATROL; SODIUM; SULFATE; SUPEROXIDE DISMUTASE; THIOCTIC ACID; TRIMETHADIONE; UNCLASSIFIED DRUG;

AGING; BRAIN ISCHEMIA; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG IDENTIFICATION; DRUG INHIBITION; DRUG MECHANISM; DRUG RESEARCH; FISH; FLY; HEART MUSCLE ISCHEMIA; KIDNEY ISCHEMIA; LIFESPAN; METABOLIC DISORDER; NONHUMAN; ORYZIAS; PUFFER FISH; REVIEW; VERTEBRATE; WORM; YEAST;

ANIMALIA; GASTEROSTEUS ACULEATUS; MAMMALIA; NOTHOBRANCHIUS FURZERI; ORYZIAS; TAKIFUGU; TETRAODON; VERTEBRATA; VITACEAE;

EID: 33646892170     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.5.10.2739     Document Type: Review

References (76)

1. Comfort A, Youhotsky-Gore I, Pathmanathan K. Effect of ethoxyquin on the longevity of C3H mice. Nature 1971; 229:254-5.
2. Knoll J. The pharmacology of selegiline ((-)deprenyl). New aspects. Acta Neurol Scand Suppl 1989; 126:83-91.
3. Jordens RG, Berry MD, Gillott C, Boulton AA. Prolongation of life in an experimental model of aging in Drosophila melanogaster. Neurochem Res 1999; 24:227-33.
4. Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell 2005; 120:483-95.
5. Schriner SE, Linford NJ, Martin GM, Treuting P, Ogburn CE, Emond M, Coskun PE, Ladiges W, Wolf N, Van Remmen H, Wallace DC, Rabinovitch PS. Extension of murine lifespan by overexpression of catalase targeted to mitochondria. Science 2005; 308:1909-11.
6. Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, Pelliccia G, Luzi L, Minucci S, Marcaccio M, Pinton P, Rizzuto R, Bernardi P, Paolucci F, Pelicci PG. Electron transfer between Cytochrome c and p66shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005; 122:221-33.
7. Migliaccio E, MG, Mele S, Pelicci G, Reboldi P, P P P, Lanfrancone L, Pelicci P. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999; 402:309-13.
8. Bauer HB, Goulpil S, Garber GB, Helfand SL. An accelerated assay for the identification of lifespan-extending interventions in Drosophila melanogaster. Proceedings of the National Academy of Sciences USA 2004; 101:12980-5.
9. Sharma SP, Wadhwa R. Effect of butylated hydroxytoluene on the life span of Drosophila bipectinata. Mechanisms of Ageing and Development 1983; 23:67-71.
10. Brack C, Bechter-Thuring E, Labuhn M. N-acetylcysteine slows down ageing andincreases the life span of Drosophila melanogaster. Cell Molecular Life Science 1997; 53:960-6.
11. Kaur M, Wadhwa R, Sharma SP. Effect of sodium solenite on antioxidative enzymes of banana fruitfly. Gerontology 1989; 35:188-91.
12. Wadhwa R, Rai N, Sharma SP. Life span studies on Zaprionus paravittiger with sodium hypophosphite feeding. Gerontology 1986; 32:141-7.
13. Wu Z, Smith JV, Paramasivam V, Btko P, Khan I, Cypser JR, Luo Y. Ginko biloba extract EGb 761 increases stress resistance and extends life span of Caenorhabditis elegans. Cell Mol Biol 2002; 48:725-31.
14. Harrington LA, Harley CB. Effect of vitamin E on lifespan and reproduction in Caenorhabditis elegans. Mechanisms of Ageing and Development 1988; 43:71-8.
15. Kang HL, Benzer S, Min KT. Life extension in Drosophila by feeding a drug. Proc Natl Acad Sci USA 2002; 99:838-43.
16. Evason K, Huang C, Yamben I, Covey DF, Kornfeld K. Anticonvulsant medications extend worm life-span. Science 2005; 307:258-62.
17. Eyal S, Yagen B, Sobol E, Altshuler Y, Shmuel M, Bialer M. The activity of antiepileptic drugs as histone deacetylase inhibitors. Epilepsia 2004; 45:737-44.
18. Melov S, Ravenscroft J, Malik S, Gill MS, Walker DW, Clayton PE, Wallace DC, Malfroy B, Doctrow SR, Lithgow GJ. Extension of life-span with superoxide dismutase/catalase mimetics. Science 2000; 289:1567-9.
19. Bayne AC, Sohal RS. Effects of superoxide dismutase/catalase mimetics on life span and oxidative stress resistance in the housefly, Musca domestica. Free Radic Biol Med 2002; 32:1229-34.
20. Keaney M, Matthijsens F, Sharpe M, Vanfleteren J, Gems D. Superoxide dismutase mimetics elevate superoxide dismutase activity in vivo but do not retard aging in the nematode Caenorhabditis elegans. Free Radic Biol Med 2004; 37:239-50.
21. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003; 425:191-6.
22. Valenzano DR, Terzibasi E, Genade T, Cattaneo A, Domenici L, Cellerino A. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol 2006; 16:296-300.
23. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, Sinclair D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004; 430:686-9.
24. Hain RB, Bieseler HaKG, Schroder R. Expression of a stilbene synthase gene in Nicotiana tabacum results in synthesis of the phytoalexin resveratrol. Plant Mol Biol 1990; 15:325-35.
25. Langcake P, Pryce RJ. A new class of phytoalexins from grape-vines. Experientia 1977; 33:151-2.
26. Celotti E, Ferrarini R, Zironi R, Conte LS. Resveratrol content of some wines obtained from dried Valpolicella grapes: Recioto and Amarone. J Chromatogr A 1996; 730:47-52.
27. Zern TL, Fernandez ML. Cardioprotective effects of dietary polyphenols. J Nutr 2005; 135:2291-4.
28. Szmitko PE, Verma S. Antiatherogenic potential of red wine: Clinician update. Am J Physiol Heart Circ Physiol 2005; 288:H2023-30.
29. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997; 275:218-20.
30. Manna SK, Mukhopadhyay A, Aggarwal BB. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 2000; 164:6509-19.
31. Wang Z, Zou J, Cao K, Hsieh TC, Huang Y, Wu JM. Dealcholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels. Int J Mol Med 2005; 16:533-40.
32. Auger C, Teissedre P, Gerain P, Lequeux N, Besancon P, Caporiccio B, Cristol J, Rouanet J. Dietary wine phenolics catecin, quercetin, and resveratrol efficiently protect hypercholesterolemic hamsters against fatty streak accumulation. J Agric Food Chem 2005; 53:2015-21.
33. Martinez J, Moreno JJ. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol 2000; 59:865-70.
34. Wang Z, Huang Y, Zou J, Cao K, Xu Y, Wu JM. Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro. Int J Mol Med 2002; 9:77-9.
35. Bertelli AA, Giovannini L, Giannessi D, Migliori M, Bernini W, Fregoni M, Bertelli A. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tissue React 1995; 17:1-3.
36. Granados-Soto V. Pleiotropic effects of resveratrol. 2003; 16:299-307, (0214-0934).
37. Ciolino HP, Yeh GC. Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol Pharmacol 1999; 56:760-7.
38. Chen ZH, Hurh YJ, Na HK, Kim JH, Chun YJ, Kim DH, Kang KS, Cho MH, Surh YJ. Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells. Carcinogenesis 2004; 25:2005-13.
39. Chun YJ, Kim MY, Guengerich FP. Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem Biophys Res Commun 1999; 262:20-4.
40. Wang Q, Xu J, Rottinghaus GE, Simonyi A, Lubahn D, Sun GY, Sun AY. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res 2002; 958:439-47.
41. Chander V, Chopra K. Role of nitric oxide in resveratrol-induced renal protective effects of ischemic preconditioning. J Vasc Surg 2005; 42:1198-205.
42. Hattori R, Otani H, Maulik N, Das DK. Pharmacological preconditioning with resveratrol: Role of nitric oxide. Am J Physiol Heart Circ Physiol 2002; 282:H1988-95.
43. Bertelli A, Bertelli AAE, Gozzini A, Giovannini L. Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exp Clin Res 1998; XXIV:133-8.
44. Wenzel E, Somoza V. Metabolism and bio availability of trans-resveratrol. Mol Nutr Food Res 2005; 49:472-81.
45. Goldberg D, Yan J, Soleas G. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem 2003; 36:79-87.
46. Goldber DM, Yan J, Soleas GJ. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem 2003; 36:79-87.
47. Pellegatta F, Bertelli AAE, Straels B, Duhem C, Fulgenzi A, Ferrero ME. Different short-and long-term effect of resveratrol on nuclear factor-kB phosphorylation and nuclear appearence in human endothelial cells. Am J Clin Nutr 2003; 77:1220-8.
48. Hattori R, Otani H, Maulik N, Das DK. Pharmacological preconditioning with resveratrol: Role of nitric oxide. Am J Physiol Heart Circ Physiol 2002; 282:1988.
49. Imamura G, Bertelli AA, Bertelli A, Otani H, Maulik N, Das DK. Pharmacological preconditioning with resveratrol: An insight with iNOS knockout mice. Am J Physiol Heart Circ Physiol 2002; 286:1996.
50. Zini R, Bertelli A, Bertelli AAE, Tillement JP. Effects of resveratrol on the rat brain respiratory chain. Drugs Exp Clin Res 1999; XXV:87-97.
51. Gledhill JR, Walker JE. Inhibition sites in F1-ATPase from bovine heart mitochondria. Biochem J 2005; 386:591-8.
52. Kaeberlein M, McVey M, Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 1999; 13:2570-80.
53. Tissenbaum HA, Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 2001; 410:227-30.
54. Rogina B, Helfand SL. Sir2 mediates longevity in the fly through a pathway related to caloric restriction. Proc Natl Acad Sci USA 2004; 101:15998-6003.
55. Kaeberlein M, McDonagh T, Heltweg B, Hixon J, Westman EA, Caldwell SD, Napper A, Curtis R, Distefano PS, Fields S, Bedalov A, Kennedy BK. Substrate-specific activation of sirtuins by resveratrol. J Biol Chem 2005; 280:17038-45.
56. Viswanathan M, Kim SK, Berdichevsky A, Guarente L. A role for SIR-2.1 regultion of ER stress response genes in determining C. Elegans life span. Developmenta Cell 2005; 9:605-15.
57. Borra MT, Smith BC, Denu JM. Mechanism of human SIRT1 activation by resveratrol. J Biol Chem 2005 280:17187-95.
58. Araki T, Sasaki Y, Milbrandt J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 2004; 305:1010-3.
59. Parker JA, Arango M, Abderrahmane S, Lambert E, Tourette C, Catoire H, Neri C. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat Genet 2005; 37:349-50.
60. Viswanathan M, Kim SK, Berdichevsky A, Guarente L. A role for SIR-2.1 regulation of ER stress response genes in determining C. elegans life span. Dev Cell 2005; 9:605-15.
61. Tatar M. SIR2 calls upon the ER. Cell Metabolism 2005; 2:281-2.
62. Weindruch R, Walford RL. The retardation of aging and desease by dietary restriction. CC Thomas, Springfield, IL: 1988.
63. Nisoli E, Tonello C, Cardile A, Cossi V, Bracale R, Tedesco L, Falcone S, Valerio A, Cantoni O, Clementi E, Moncada S, Carruba M. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 2005; 310:314-7.
64. Miller RA, Harper JM, Dysko RC, Durkee SJ, Austad SN. Longer life spans and delayed maturation in wild-derived mice. Exp Biol Med (Maywood) 2002; 227:500-8.
65. Gerhard GS, Malek RL, Keller E, Murtha J, Cheng KC. Zebrafish, killifish, neither fish, both fish? J Gerontol A Biol Sci Med Sci 2004; 59:B873-5.
66. Genade T, Benedetti M, Terzibasi E, Roncaglia P, Valenzano DR, Cattaneo A, Cellerino A. Annual fishes of the genus Nothobranchius as a model system for aging research. Aging Cell 2005; 4:223-33.
67. Valdesalici S, Cellerino A. Extremely short lifespan in the annual fish Nothobranchius furzeri. Proc R Soc Lond B Biol Sci 2003; 270(Suppl 2:S189-91).
68. Pletcher SD. Model fitting and hypothesis testing for age'specific mortality data. J Evol Biol 1999; 12:430-9.
69. Pletcher SD. Winmodest. In: Pletcher SD, ed. Research MPIfD. Rostock, Germany: 1999.
70. Finch CE, Pike MC, Witten M. Slow mortality rate accelerations during aging in some animals approximate that of humans. Science 1990; 249:902-5.
71. Lamming DW, Wood JG, Sinclair DA. Small molecules that regulate lifespan: Evidence for xenohormesis. Mol Microbiol 2004; 53:1003-9.
72. Anson RM, Guo Z, de Cabo R, Iyun T, Rios M, Hagepanos A, Ingram DK, Lane MA, Mattson MP. Intermittent fasting dissociates beneficial effects of dietary restriction on glucose and neuronal resistence to injury from calorie intake. Proc J Acad Sci USA 2003; 100:6216-20.
73. Masoro EJ, Yu PB, Bertrand HA. Action of food restriction in delaying the aging process. Proc J Acad Sci USA 1982; 79:4239-41.
74. Gavrilov LA, Gavrilova NS. Evolutionary theories of aging and longevity. Sci World J 2002; 2:339-56.
75. Kirkwood TBL. Evolution of aging. Nature 1977; 270:301-4.
76. Herrera M, Jagadeeswaran P. Annual fish as a genetic model for aging. J Gerontol A Biol Sci Med Sci 2004; 59:101-7.